Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00979225 · ClinicalTrials.gov registry record · NA

Clinical Decision Support for Medication Management and Adherence

A NA study of Hypertension and Stroke, sponsored by Duke University.

Completed
Registry status
NA
Development phase
5,000
Enrollment target
1
Study location

NCT00979225 is a NA study of Hypertension and Stroke that has completed, run by Duke University. The registered enrollment target is 5,000 participants, above the 3,497-participant average among 470 other Hypertension trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00979225, a NA study of Hypertension and Stroke, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
5,000 participants
Enrollment target
1
Study location

Study Summary

This three-year, grant funded project will be conducted by the Division of Clinical Informatics in the Department of Community and Family Medicine at Duke University Medical Center. The project seeks to improve care quality and safety in an ambulatory care setting through clinical decision support for evidence-based (EB) pharmacotherapy delivered as point-of-care reports to clinic-based practitioners and as population health-based alerts to care managers. This project will build upon a regional Health Information Exchange (HIE) network created to connect providers serving 37,000 Medicaid beneficiaries from both rural and urban settings in a 5 county region in the Northern Piedmont of North Carolina. This network includes 16 private practices, 3 federally qualified health centers, 5 rural health centers, 3 urgent care facilities, 10 government agencies, 5 hospitals, and 2 cross-disciplinary care management teams. The proposed information system will be based on an emerging standard for decision support and will utilize routinely available claims and scheduling data in order to serve as a replicable model for broader use of decision support for medication management. Increased availability and use of decision support tools for medication management can be expected to reduce medication errors, improve health care quality at an acceptable cost, and augment disease management for patients and populations.

Interventions

  • OTHER Medication Management report
  • OTHER Care manager email notices

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2009-09
Est. Completion 2012-03
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00979225

The ClinicalTrials.gov registry entry for NCT00979225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,497-participant average among 470 other Hypertension trials with a reported enrollment target (43% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Medication Management report is the first listed.

NCT00979225 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00979225 about?

NCT00979225 is a clinical study titled "Clinical Decision Support for Medication Management and Adherence". This three-year, grant funded project will be conducted by the Division of Clinical Informatics in the Department of Community and Family Medicine at Duke University Medical Center. The project seeks to improve care quality and safety in an ambulatory care setting through clinical decision support f...

What is the current status of trial NCT00979225?

This trial is currently completed. It is a NA study. The enrollment target is 5,000 participants. The study started on 2009-09. Estimated completion is 2012-03.

What conditions does trial NCT00979225 study?

This clinical trial studies the following conditions: Hypertension, Stroke, Heart Failure, Asthma, Diabetes Mellitus.

What interventions are being tested in trial NCT00979225?

The interventions under investigation include: Medication Management report (OTHER), Care manager email notices (OTHER).

Who is sponsoring clinical trial NCT00979225?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00979225 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.